Imatinib mesylate therapy in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia: high incidence of early complete and major cytogenetic responses.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples